Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Glass

Showing results (121-130 of 125) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 125 results.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 9, 2020
A novel allosteric modulator of the cannabinoid CB<sub>1</sub> receptor ameliorates hyperdopaminergia endophenotypes in rodent modelsCatharine A Mielnik, Kim S Sugamori, David B Finlay, et al.
Nature Communications|January 4, 2017
Cannabinoid CB<sub>2</sub> receptor ligand profiling reveals biased signalling and off-target activityMarjolein Soethoudt, Uwe Grether, Jürgen Fingerle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2012
Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patientsLaszlo G Radvanyi, Chantale Bernatchez, Minying Zhang, et al.
Nature Medicine|June 8, 2023
Signaling-specific inhibition of the CB<sub>1</sub> receptor for cannabis use disorder: phase 1 and phase 2a randomized trialsMargaret Haney, Monique Vallée, Sandy Fabre, et al.
British Journal of Pharmacology|December 29, 2025
The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptorsStephen P H Alexander, Anthony P Davenport, Eamonn Kelly, et al.
Pageof 13

Showing results (121-130 of 125) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 125 results.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 9, 2020
A novel allosteric modulator of the cannabinoid CB<sub>1</sub> receptor ameliorates hyperdopaminergia endophenotypes in rodent modelsCatharine A Mielnik, Kim S Sugamori, David B Finlay, et al.
Nature Communications|January 4, 2017
Cannabinoid CB<sub>2</sub> receptor ligand profiling reveals biased signalling and off-target activityMarjolein Soethoudt, Uwe Grether, Jürgen Fingerle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2012
Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patientsLaszlo G Radvanyi, Chantale Bernatchez, Minying Zhang, et al.
Nature Medicine|June 8, 2023
Signaling-specific inhibition of the CB<sub>1</sub> receptor for cannabis use disorder: phase 1 and phase 2a randomized trialsMargaret Haney, Monique Vallée, Sandy Fabre, et al.
British Journal of Pharmacology|December 29, 2025
The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptorsStephen P H Alexander, Anthony P Davenport, Eamonn Kelly, et al.
Pageof 13